Literature DB >> 8394299

Mitogauzone, cisplatin, and vinblastine in advanced non-small cell lung cancer: a Southwest Oncology Group study.

R Chapman1, J Crowley, J G Lucas, B L Hom, R B Livingston, C B Vaughn, H E Hynes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8394299     DOI： 10.1007/bf00873920

Source DB:  PubMed          Journal:  Invest New Drugs        ISSN： 0167-6997            Impact factor:   3.850


× No keyword cloud information.
  2 in total

1.  Cisplatin, vindesine and bleomycin (CVB) combination chemotherapy of advanced non-small cell lung cancer.

Authors:  L M Itri; R J Gralla; D P Kelsen; R A Chapman; E S Casper; D W Braun; J E Howard; R Golbey; R T Heelan
Journal:  Cancer       Date:  1983-03-15       Impact factor: 6.860

2.  Cisplatin and vindesine combination chemotherapy for advanced carcinoma of the lung: A randomized trial investigating two dosage schedules.

Authors:  R J Gralla; E S Casper; D P Kelsen; D W Braun; M E Dukeman; N Martini; C W Young; R B Golbey
Journal:  Ann Intern Med       Date:  1981-10       Impact factor: 25.391
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.